Rezolute, Inc. (RZLT)
4.69
+0.07
(+1.52%)
USD |
NASDAQ |
Aug 31, 16:00
4.685
0.00 (0.00%)
After-Hours: 20:00
Rezolute Total Long Term Debt (Quarterly) : 0.438M for March 31, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.438M |
| December 31, 2025 | 0.619M |
| September 30, 2025 | 0.804M |
| June 30, 2025 | 0.983M |
| March 31, 2025 | 1.16M |
| December 31, 2024 | 1.333M |
| September 30, 2024 | 1.499M |
| June 30, 2024 | 1.66M |
| March 31, 2024 | 1.819M |
| December 31, 2023 | 1.975M |
| September 30, 2023 | 1.814M |
| June 30, 2023 | 1.937M |
| March 31, 2023 | 2.055M |
| December 31, 2022 | 2.196M |
| September 30, 2022 | 0.049M |
| June 30, 2022 | 0.08M |
| March 31, 2022 | 14.39M |
| December 31, 2021 | 14.31M |
| September 30, 2021 | 14.23M |
| June 30, 2021 | 14.16M |
| March 31, 2021 | 0.213M |
| December 31, 2020 | 0.281M |
| September 30, 2020 | 0.104M |
| June 30, 2020 | 0.165M |
| March 31, 2020 | 0.224M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.287M |
| September 30, 2019 | 0.346M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 7.267M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0231M |
| March 31, 2016 | 0.0469M |
| December 31, 2015 | 0.0705M |
| September 30, 2015 | 0.0939M |
| June 30, 2015 | 0.117M |
| March 31, 2015 | 0.1398M |
| December 31, 2014 | 0.1625M |
| September 30, 2014 | 0.2449M |
| June 30, 2014 | 0.06M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 0.157M |
| AbbVie, Inc. | 70.82B |
| Marker Therapeutics, Inc. | 0.00 |
| Avalo Therapeutics, Inc. | 2.00M |
| Krystal Biotech, Inc. | 7.045M |